As of 2024-12-14, the Intrinsic Value of Brooklyn Immunotherapeutics Inc (BTX) is
0.00 USD. This BTX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.21 USD, the upside of Brooklyn Immunotherapeutics Inc is
-99.80%.
BTX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
0.00 - 0.00 |
0.00 |
-99.80% |
| P/E |
(2.51) - (2.22) |
(2.39) |
-1263.9% |
| DDM - Stable |
(0.49) - (1.34) |
(0.92) |
-547.1% |
| DDM - Multi |
(0.42) - (0.91) |
(0.58) |
-380.9% |
BTX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
14.72 |
| Beta |
4.57 |
| Outstanding shares (mil) |
71.76 |
| Enterprise Value (mil) |
14.96 |
| Market risk premium |
5.00% |
| Cost of Equity |
10.46% |
| Cost of Debt |
5.00% |
| WACC |
9.52% |